Range
3.15 - 3.4
Vol / Avg.
484.8K/791K
Div / Yield
-
52 Wk
3.23 - 30.14
Mkt Cap
120.4M
Payout Ratio
-
Open
3.38
P/E
-
EPS
-0.69
Shares
38.2M
Outstanding
load more
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-03-10
REV
Q3 2021Est.ActualSurprise
EPS-0.690
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

TCR2 Therapeutics Questions & Anwsers

Q

How do I buy TCR2 Therapeutics (TCRR) stock?

A

You can purchase shares of TCR2 Therapeutics (NASDAQ: TCRR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TCR2 Therapeutics's (TCRR) competitors?

Q

What is the target price for TCR2 Therapeutics (TCRR) stock?

A

The latest price target for TCR2 Therapeutics (NASDAQ: TCRR) was reported by Goldman Sachs on January 19, 2022. The analyst firm set a price target for 5.00 expecting TCRR to rise to within 12 months (a possible 58.73% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TCR2 Therapeutics (TCRR)?

A

The stock price for TCR2 Therapeutics (NASDAQ: TCRR) is $3.15 last updated Today at 9:00:03 PM.

Q

Does TCR2 Therapeutics (TCRR) pay a dividend?

A

There are no upcoming dividends for TCR2 Therapeutics.

Q

When is TCR2 Therapeutics (NASDAQ:TCRR) reporting earnings?

A

TCR2 Therapeutics’s $Q4 earnings are confirmed for after-market on March 10, 2022.

Q

Is TCR2 Therapeutics (TCRR) going to split?

A

There is no upcoming split for TCR2 Therapeutics.

Q

What sector and industry does TCR2 Therapeutics (TCRR) operate in?

A

TCR2 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.